Answer
It is an anticancer immunotherapy rather than conventional cytotoxic chemotherapy. It redirects T cells towards uveal melanoma cells carrying a specific gp100 and HLA target.
Sources for this answer
- KIMMTRAK (tebentafusp) 200 micrograms/ mL concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
- PubMedPubMed · Reputable Web
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.